echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: What is the risk of fracture in stroke patients treated with selective serotonin reuptake inhibitors?

    Stroke: What is the risk of fracture in stroke patients treated with selective serotonin reuptake inhibitors?

    • Last Update: 2021-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Stroke survivors have an increased risk of depression and fractures
    .


    Observational studies indicate that selective serotonin reuptake inhibitors (SSRIs) are associated with increased fracture risk


    Stroke

    Recently, the heart blood vessels published on the prestigious journal Stroke disease area research article, the researchers sought to determine stroke survivors and fracture risk associated with the use of SSRIs and falls,The risk of epilepsy and recurrent stroke
    .

    Heart blood vesselsepilepsy


    According to the protocol registered in PROSPERO (CRD42020192632), the researchers conducted a systematic review and meta-analysis of RCTs for assessing the effects of SSRIs among stroke survivors
    .


    Researchers searched WebofScience, EMBASE, PsycINFO and OvidMedline/PubMed databases, clinical trial grade centers, and grey literature to determine RCTs that compared SSRIs with placebo or no intervention and reported fracture risk in adult survivors of hemorrhagic or ischemic stroke.



     
    The researchers retrieved a total of 683 records, including 4 RCTs with a duration of 6 months.


    A total of 6549 participants were included in the meta-analysis: 3 studies of fluoxetine and 1 study of citalopram


    According to the existing RCTs of fluoxetine and citalopram, the use of SSRI for 6 months doubled the risk of fracture in stroke survivors


    Original source:

    Joshua S.


    Jones.
    et al.
    Risk of Fractures in Stroke Patients Treated With a Selective Serotonin Reuptake Inhibitor A Systematic Review and Meta-Analysis .
    stroke.
    2021.


    Risk of Fractures in Stroke Patients Treated With a Selective Serotonin Reuptake Inhibitor A Systematic Review and Meta-Analysis In this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.